Otsuka Pharmaceutical has hit back at suit filed by Indian generics company Sun Pharma seeking to invalidate its patent for blockbuster antipsychotic Abilify, filing a cross-claim seeking to restrain Sun Pharma from infringing the patent with a generic version of the drug.
Drug giant Glaxo has succeeded in extending the term for a patent for a drug that treats chronic obstructive pulmonary disease and asthma, with a delegate rejecting arguments from law firm Banki Haddock Fiora that the application was incorrectly based on a patent that was no longer valid because of amendments.
Medicinal cannabis company Vitura Health has won its bid for orders restricting the access of a software partner to its IT systems after an alleged hack.
South Korean biotech ToolGen has won court approval to patent its genome editing technology CRISPR, after an earlier bid to protect its IP found the revolutionary technology was not patentable.
Ramsay Health Care has won a partial interim injunction banning the union representing its nurses from running ads that claim the private hospital operator runs on a staff-to-patient ratio double that of public hospitals.
Medibank CEO David Koczkar has taken the stand to help defeat a class actionâs bid to uncover several reports, including three by Deloitte, commissioned in the wake of a massive data breach, which the health insurer argues are privileged.
Federal police are investigating a large-scale data breach at an unnamed commercial health information organisation, the National Cyber Security Coordinator has revealed.Â
A court has granted an extension to the limitation period for a pelvic mesh patient suing her doctor for negligence, finding she did not have the knowledge to bring the case before the three-year window closed and that her claim for substantial damages for personal injury appeared âwell foundedâ.Â
A cyberattack has compromised the confidential data of thousands of sexual assault and family violence victims who were patients of Monash Health clinics.
Charges accusing Victoria’s Department of Health of health and safety breaches during the state’s hotel quarantine program have been dropped on the eve of trial, after the state succeeded in excluding evidence submitted to an inquiry into the disastrous program.